Gum disease vaccine in development
Links shared publicly online about this topic.
- 1,514total visits
Gum disease vaccine in development
View full resource at dentalplans.com
Tags: Vaccination, Dental, Gum Disease, Disease and Condition, Vaccine
Most Recently Shared on December 21, 2009 at 7:46 pm By:
Gum disease vaccine in development … http://bit.ly/8ofTrC
Treatment of Gum Disease Benefits Diabetics - EmpowHER.com
empowher.com — “Since oral health is directly linked to diabetes, it's important to maintain healthy gums and dental care if you are diabetic. Diabetes can initiate the development of gum (periodontal) disease, putting one at risk for further complications and causing an influx in health care costs if left untreated.” View full resource at empowher.com
Most Recently Shared on March 29, 2012 at 9:40 pm By:
A 24-karat gold key to unlock the immune system
labspaces.net — “Developing a drug or vaccine requires a delicate balancing act with the immune system. On one hand, medications need to escape detection by the immune system in order to perform their function. But vaccinations — de-activated versions of a disease or virus — need to do the reverse. They prompt the immune system to create protective antibodies. But scientists are still stumped by how the immune sys” View full resource at labspaces.net
Most Recently Shared on March 26, 2012 at 9:30 pm By:
A 24-karat gold key to unlock the immune system - http://t.co/INNOKp5m
Whooping Cough Bacteria May Be Changing Their Ways In Australia : Shots - Health Blog : NPR
npr.org — “Whooping cough has reappeared in the U.S. and other developed countries in recent years, despite widespread use of vaccines. Researchers in Australia offer a partial explanation: they say the vaccine isn't tailored to fight some of the most common strains of the bacteria.” View full resource at npr.org
Most Recently Shared on March 24, 2012 at 5:55 pm By:
#WhoopingCough #bacteria may be changing their ways in #Australia http://t.co/GdMw306w #pertussis #vaccine #infectious #disease
Whooping Cough Bacteria May Be Changing Their Ways In Australia : Shots - Health Blog : NPR
npr.org — “Whooping cough has reappeared in the U.S. and other developed countries in recent years, despite widespread use of vaccines. Researchers in Australia offer a partial explanation: they say the vaccine isn't tailored to fight some of the most common strains of the bacteria.” View full resource at npr.org
Most Recently Shared on March 23, 2012 at 7:45 pm By:
Whooping Cough Bacteria May Be Changing Their Ways In Australia http://t.co/EqcxnP1e
Whooping Cough Bacteria May Be Changing Their Ways In Australia : Shots - Health Blog : NPR
npr.org — “Whooping cough has reappeared in the U.S. and other developed countries in recent years, despite widespread use of vaccines. Researchers in Australia offer a partial explanation: they say the vaccine isn't tailored to fight some of the most common strains of the bacteria.” View full resource at npr.org
Most Recently Shared on March 23, 2012 at 7:10 pm By:
JHU Public Health Medical School
Whooping cough is making a comeback; one factor is spotty vaccination: http://t.co/5JnO75BD via @NPRHealth
Emergent receives NIAID grant to advance development of MVA85A TB vaccine
news-medical.net — “Emergent BioSolutions Inc. today announced that it has received a multi-year grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to advance the development of MVA85A, a candidate vaccine against tuberculosis.” View full resource at news-medical.net
Most Recently Shared on March 23, 2012 at 10:56 am By:
News-Medical.Net Oncology and Health News
Oncology News: Emergent receives NIAID grant to advance development of MVA85A TB vaccine: Emergent BioSolutions ... http://t.co/UC1VKbHa
U of S professor receives Canada Gairdner Wightman Award
news-medical.net — “University of Saskatchewan Professor Emeritus Lorne Babiuk has been awarded the prestigious Canada Gairdner Wightman Award in recognition of his accomplishments over three decades that include leading the U of S Vaccine and Infectious Disease Organization (VIDO) to become a world centre for vaccine research, training and development.” View full resource at news-medical.net
Most Recently Shared on March 22, 2012 at 1:55 pm By:
U of S professor receives Canada Gairdner Wightman Award: University of Saskatchewan Professor Emeritus Lorne Ba... http://t.co/f1zVTUFS
U of S professor receives Canada Gairdner Wightman Award
news-medical.net — “University of Saskatchewan Professor Emeritus Lorne Babiuk has been awarded the prestigious Canada Gairdner Wightman Award in recognition of his accomplishments over three decades that include leading the U of S Vaccine and Infectious Disease Organization (VIDO) to become a world centre for vaccine research, training and development.” View full resource at news-medical.net
Most Recently Shared on March 22, 2012 at 10:36 am By:
West Nile Virus: U of S professor receives Canada Gairdner Wightman Award: University of Saskatchewan Professor ... http://t.co/yvoE9ffA
New vaccine strategy to advance solutions for tuberculosis
news-medical.net — “Against a backdrop of growing concern about the impact of tuberculosis on children, top scientific experts today published a global plan of action for developing the vaccines that are seen as critical to eliminating the disease. Published today in a special issue of the journal, Tuberculosis , the strategic blueprint for the TB vaccine field, represents consensus reached by the TB vaccine community.” View full resource at news-medical.net
Most Recently Shared on March 21, 2012 at 1:06 am By:
New vaccine strategy to advance solutions for tuberculosis: Against a backdrop of growing concern about the impa... http://t.co/kKXG245y
New vaccine strategy to advance solutions for tuberculosis
eurekalert.org — “Against a backdrop of growing concern about the impact of tuberculosis on children, top scientific experts today published a global plan of action for developing the vaccines that are seen as critical to eliminating the disease. Published today in a special issue of the journal, Tuberculosis, the strategic blueprint for the TB vaccine field, represents consensus reached by the TB vaccine community.” View full resource at eurekalert.org
Most Recently Shared on March 20, 2012 at 8:01 pm By:
New vaccine strategy to advance solutions for #tuberculosis : http://t.co/mXcoq9sd #TB
Advaxis Continues Collaboration with Former NCI Vaccines Chief in New Position as Director of the Georgia Health Sciences University Cancer Center | BioPortfolio.com
bioportfolio.com — “From BioPortfolio: Advaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced it will continue its c...” View full resource at bioportfolio.com
Most Recently Shared on March 20, 2012 at 2:08 pm By:
BioPortfolio News Advaxis Continues Collaboration with Former NCI Vaccines Chief in New Positi... http://t.co/K11NjY5b BioPortfolio News
PaxVax announces FDA acceptance of IND for PXVX-0200 cholera vaccine
news-medical.net — “PaxVax Corporation, developer of innovative and socially responsible oral vaccines against infectious diseases, announced that the U.S. Food and Drug Administration (FDA) has accepted its investigational new drug (IND) application for its single-dose oral cholera vaccine, clearing the way to begin clinical trials. The company intends to begin Phase 3 trials later this year.” View full resource at news-medical.net
Most Recently Shared on March 19, 2012 at 1:12 pm By:
Bird Flu News: PaxVax announces FDA acceptance of IND for PXVX-0200 cholera vaccine: PaxVax Corporation, develop... http://t.co/vN7utz5a
Advaxis Named to Shortlist for Vaccine Industry Excellence Award - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: Advaxis, Inc., , a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has been selected for the shortlist of the 5th Annual Vaccine Industry Excellence Awards in the category of Best Therapeutic Vaccine for its ADXS-HPV construct.” View full resource at finance.yahoo.com
Most Recently Shared on March 19, 2012 at 1:03 pm By:
Advaxis Named to Shortlist for Vaccine Industry Excellence Award: Advaxis, Inc., , a leader in developing the ne... http://t.co/AcWxFjM9
FDA Accepts PaxVax’s IND for Single-Dose Oral Cholera Vaccine - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: PaxVax Corporation, developer of innovative and socially responsible oral vaccines against infectious diseases, announced that the U.S. Food and Drug Administration has accepted its investigational new drug application for its single-dose oral cholera vaccine, clearing the way to begin clinical trials.” View full resource at finance.yahoo.com
Most Recently Shared on March 19, 2012 at 1:03 pm By:
FDA Accepts PaxVax’s IND for Single-Dose Oral Cholera Vaccine: PaxVax Corporation, developer of innovative and s... http://t.co/S88mL9v2
USPTO issues two patents on 'Novel Shigella protein antigens and methods' to IVI
news-medical.net — “The International Vaccine Institute (IVI), an international organization based in Seoul devoted to research on the development and introduction of vaccines for the developing world, reached a milestone in its aim to prevent and control dysentery (also commonly called shigellosis or bloody diarrhea), a deadly disease that affects several million people worldwide.” View full resource at news-medical.net
Most Recently Shared on February 28, 2012 at 8:38 am By:
Meningitis News: USPTO issues two patents on 'Novel Shigella protein antigens and methods' to IVI: The Internati... http://t.co/mgsZ4nGF
Advertisement
